Development of a multiplex point-of-care-test to improve diagnosis and treatment of complement-mediated kidney diseases

被引：0

作者：

van Bree, Bregje ^{[1
]}

Mulleder, Bertina ^{[2
]}

Grabner, Johanna ^{[2
]}

Stevens, Kes ^{[3
]}

van de Kara, Nicole C. A. J. ^{[3
]}

van den Heuvel, Lambertus P. ^{[3
]}

Ladenhauf, Nikolaus ^{[2
]}

Sonnleitner, Max ^{[2
]}

Toonen, Erik ^{[1
]}

机构：

[1] Hycult Biotech, R&D Dept, Uden, Netherlands

[2] GENSPEED Biotech, Rainbach, Austria

[3] Radboud Univ Nijmegen Med Ctr, Amalia Childrens Hosp, Dept Pediat Nephrol, Nijmegen, Netherlands

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P 52

引用

页码：107 / 107

页数：1

共 50 条

[21] Complement-mediated renal diseases after kidney transplantation: a natural history study in idiopathic membranoproliferative glomerulonephritis (MPGN)
Martinattol, Carolina
Manisa, Maddalena
Nanchen, Giliane
Breno, Matteo
Rigoldi, Miriam
Noris, Marina
Bresin, Elena
Gamba, Sara
Bottanelli, Laura
Imanifard, Zahra
Piras, Rossella
Donadelli, Roberta
Mele, Caterina
Benigni, Ariela
Remuzzi, Giuseppe
Daina, Erica
EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 79 - 80
[22] Characterizing a potential third class of C3 nephritic factors in patients with complement-mediated kidney diseases
Stevens, Kes H.
Maas, Rianne J. F.
Volokhina, Elena B.
Ponfoort, Marnix
van de Karl, Nicole C. A. J.
van den Heuvel, Lambertus P.
Michels, Marloes A. H. M.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 120 - 120
[23] BCX9930, an Oral Factor D Inhibitor in Development for Treatment of Complement-Mediated Diseases, Inhibits Complement Alternative Pathway (AP) Activity in Healthy Subjects
Chen, Xilin
Zhu, Fugang
Parker, Cynthia D.
Cornpropst, Melanie
Sheridan, William P.
Davidson, Matthew
Babu, Yarlagadda S.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 516 - 516
[24] Immunoglobulin and complement-mediated glomerular diseases with an MPGN pattern of injury: Unmasking the diagnosis of lupus in a patient with hepatitis A infection
Nimmo, Ailish
Zhou, Qiaoling
Chatzitolios, Anastasios
Bailey, Phillippa
CLINICAL CASE REPORTS, 2021, 9 (04): : 2083 - 2087
[25] Development of RA101348, a potent cyclic peptide inhibitor of C5 for complement-mediated diseases
Ricardo, Alonso
Arata, Michelle
DeMarco, Steven
Dhamnaskar, Ketki
Hammer, Robert
Josephson, Kristopher
Seyb, Kathleen
Tobe, Sylvia
Wang, Zhaolin
Zheng, Hong
Treco, Douglas
MOLECULAR IMMUNOLOGY, 2015, 67 (01) : 173 - 174
[26] Development of RA101348, a Potent Cyclic Peptide Inhibitor of C5 for Complement-Mediated Diseases
Ricardo, Alonso
Arata, Michelle
DeMarco, Steven J.
Dhamnaskar, Ketki
Hammer, Robert
Josephson, Kristopher
Seyb, Kathleen
Tobe, Sylvia
Wang, Zhaolin
Zheng, Hong
Treco, Douglas
BLOOD, 2014, 124 (21)
[27] Complement-Mediated Thrombotic Microangiopathy after Kidney Transplant: Should Treatment with C5 Inhibitor Be Lifelong?
Musalem, Pilar
Pedreros-Rosales, Cristian
Muller-Ortiz, Hans
Gutierrez-Navarro, Carlos
Carpio, J. Daniel
NEPHRON, 2024,
[28] A new point-of-care test for the diagnosis of infectious diseases based on multiplex lateral flow immunoassays (vol 144, pg 2460, 2019)
Kim, Hanbi
Chung, Doo-Ryeon
Kang, Minhee
ANALYST, 2019, 144 (17) : 5308 - 5308
[29] Development of a rapid point of care test for the diagnosis of hepatitis C infection
Lee, S. R.
Kardos, K. W.
Guillon, G.
Mokkapati, V.
Fischl, M.
Kurtz, L.
Schultz, H.
CLINICAL CHEMISTRY, 2006, 52 (06) : A43 - A44
[30] Multiplex loop mediated isothermal amplification (m-LAMP) as a point of care technique for diagnosis of malaria
Sharma, Supriya
Singh, Jaskirat
Sen, Aparajita
Anvikar, Anupkumar
JOURNAL OF VECTOR BORNE DISEASES, 2022, 59 (01) : 29 - 36

← 1 2 3 4 5 →